ISSN: 1479-6708

Journal Home

Journal Guideline

Future Neurology Q4 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Future Neurology is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 39. It has a price of 2083 €. It has an SJR impact factor of 0,193 and it has a best quartile of Q4. It has an SJR impact factor of 0,193.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Neurology (Q4) Neurology (clinical) (Q4) Neurology (clinical) (Q4)

Price

2083 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,193

SJR Impact factor

39

H Index

10

Total Docs (Last Year)

27

Total Docs (3 years)

510

Total Refs

19

Total Cites (3 years)

25

Citable Docs (3 years)

0.33

Cites/Doc (2 years)

51.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Neuroforum Q4
Ideggyogyaszati Szemle Q4
Journal of Brachial Plexus and Peripheral Nerve Injury Q4
Case Reports in Neurology Q4
Acta Neurologica Taiwanica Q4

Compare this journals

Aims and Scope

Best articles by citations

Brain lesions and emotional disorders

Infection as a risk factor for stroke

Biomarkers to advance drug development for Alzheimer's disease

HIV-associated neurocognitive disorders: a changing pattern

Transplantation of mesenchymal stem cells: a future therapy for Parkinson's disease?

The OPTIMISE data project: toward improving multiple sclerosis treatment

Monitoring increased iron levels in multiple sclerosis using MRI

LRP1 and cerebral amyloid angiopathy

Gene-expression profiling in Parkinson's disease: discovery of valid biomarkers, molecular targets and biochemical pathways

Neuroimaging of epilepsy: a review of MRI findings in uncommon etiologies and atypical presentations of seizures

Disease-modifying therapy for multiple sclerosis

LRRK2 mutations, regulation and 14-3-3 protein interaction: implications for Parkinson's disease

SHOW MORE ARTICLES

Diagnosis of schizophrenia: a 19th Century concept not fit for 21st Century science

Important role of brain reserve in lowering the risk of Alzheimer's disease

Neurorehabilitation issues in states of disordered consciousness following traumatic brain injury

Clazosentan: a review of subarachnoid hemorrhage data

Long-term memory persistence

Oxidative stress: a hallmark of Rett syndrome

Transcendent leadership

Alzheimer's disease and schizophrenia: evidence of a specific, shared molecular background

Current developments in MRI for assessing rodent models of multiple sclerosis

Oncolytic parvovirus for cancer of the brain: are we approaching human trials?

Lipid connection to bipolar disorder

Agrin in the nervous system: synaptogenesis and beyond